Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$251K Hold
4,000
0.09% 185
2025
Q4
$265K Hold
4,000
0.08% 166
2025
Q3
$269K Hold
4,000
0.09% 173
2025
Q2
$349K Hold
4,000
0.13% 127
2025
Q1
$273K Buy
+4,000
New +$326K 0.11% 151

Other funds holding DXCM

Wealth Effects's DXCM Position: Q1 2026 in Review

Wealth Effects held its DexCom (DXCM) position steady in Q1 2026 at 4,000 shares worth $251K. The position accounts for 0.09% of the portfolio, ranked #185.

Wealth Effects first reported a position in DXCM in Q1 2025 and has held it in 5 quarters since. The position peaked at $349K in Q2 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Wealth Effects held 4,000 shares of DexCom worth $251K as of Q1 2026.
  • Wealth Effects left its DexCom share count unchanged in Q1 2026.
  • DexCom made up 0.09% of Wealth Effects's portfolio in Q1 2026, its #185 holding.
  • Wealth Effects first reported a position in DexCom in Q1 2025 and has held it in 5 quarters since.
  • Wealth Effects's DexCom position peaked at $349K in Q2 2025.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Wealth Effects's 13F filing for Q1 2026, filed 21 Apr 2026.